Trade Mark Journal No.2026/019 8 May 2026
WO0000001913822 (5,10,42,44)
Office of origin: United States of America
Date of International Registration:17 March 2026
Date of designation in the UK:
17 March 2026
Registration of this mark shall give no right to the exclusive use of "THERAPEUTICS".
International priority date claimed: 31 December 2025
(United States of America)
(99573427)
- Class 5
- Pharmaceutical preparations for the treatment of immune system related diseases and disorders, autoimmune diseases, cancer, inflammation and autoinflammation diseases by use in extracorporeal photopheresis, extracorporeal photo immune therapy, extracorporeal photo chemotherapy and cellular therapies.
- Class 10
- Medical device, namely, therapeutic medical device for extracting blood from the body, separating blood, treating it extra corporally, and returning it to the body, used for extra corporeal photopheresis, extra corporeal photo immune therapy, extra corporeal photo chemotherapy, and cellular therapies.
- Class 42
- Pharmaceutical research services; pharmaceutical products development.
- Class 44
- Medical and pharmaceutical consultation; medical services relating to extra corporeal photopheresis, extra corporeal photo immune therapy, extra corporeal photo chemotherapy, and cellular therapies.
Therakos, LLC
Representative: Adrienne Love Stearns Weaver Miller Weissler Alhadeff & Sitterso, 106 East College Avenue, , Suite 700, Tallahassee FL 32301, UNITED STATES OF AMERICA